(Q40877722)

24 September 2017

title

Selective targeting of immunoliposomal doxorubicin against human multiple myeloma in vitro and ex vivo (English)

1 reference

24 September 2017

1 reference

D E Lopes de Menezes

1

1 reference

24 September 2017

L M Pilarski

series ordinal

2

1 reference

24 September 2017

A R Belch

series ordinal

3

1 reference

24 September 2017

T M Allen

series ordinal

4

1 reference

24 September 2017

publication date

1 June 2000

1 reference

Biochimica et Biophysica Acta

24 September 2017

published in

1 reference

24 September 2017

volume

1466

1 reference

24 September 2017

issue

1-2

1 reference

24 September 2017

page(s)

205-220

1 reference

Multiple myeloma and related plasma cell dyscrasias

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900203-0

Chronic lymphocytic leukemia with an interfollicular architecture: avoiding diagnostic confusion with monocytoid B-cell lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900203-0

Expression of multiple beta 1 integrins on circulating monoclonal B cells in patients with multiple myeloma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900203-0

Intrinsic expression of the multidrug transporter, P-glycoprotein 170, in multiple myeloma: implications for treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900203-0

Construction and characterisation of a functional CD19 specific single chain Fv fragment for immunotherapy of B lineage leukaemia and lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900203-0

Regulatory role of CD19 molecules in B-cell activation and differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900203-0

The potential of targeted radiotherapy in the treatment of central nervous system leukaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900203-0

Preclinical studies with radiolabeled monoclonal antibodies for treatment of patients with B-cell malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900203-0

Initial experience with treatment of human B cell lymphoma with anti-CD19 monoclonal antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900203-0

Immunoliposome-mediated targeting of anti-cancer drugs in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900203-0

7 January 2021

Immunoliposomes in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900203-0

Immunoliposomes for cancer treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900203-0

Characterization of organ-specific immunoliposomes for delivery of 3',5'-O-dipalmitoyl-5-fluoro-2'-deoxyuridine in a mouse lung-metastasis model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900203-0

Liposomes composed of partially hydrogenated egg phosphatidylcholines: fatty acid composition, thermal phase behavior and oxidative stability.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900203-0

Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900203-0

Synthesis of an end-group functionalized polyethylene glycol-lipid conjugate for preparation of polymer-grafted liposomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900203-0

Preparation and characterization of a chimeric CD 19 monoclonal antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900203-0

Use of radiolabeled hexadecyl cholesteryl ether as a liposome marker

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900203-0

Processing of different liposome markers after in vitro uptake of immunoglobulin-coated liposomes by rat liver macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900203-0

Vesicles of variable sizes produced by a rapid extrusion procedure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900203-0

Attachment of antibodies to sterically stabilized liposomes: evaluation, comparison and optimization of coupling procedures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900203-0

Endocytosis of liposomes by macrophages: binding, acidification and leakage of liposomes monitored by a new fluorescence assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900203-0

Endocytosis and intracellular fate of liposomes using pyranine as a probe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900203-0

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900203-0

Mithramycin- and 4'-6-diamidino-2-phenylindole (DAPI)-DNA staining for fluorescence microspectrophotometric measurement of DNA in nuclei, plastids, and virus particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900203-0

Application of DNA flow cytometry to paraffin-embedded archival material for the study of aneuploidy and its clinical significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900203-0

Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900203-0

Biological activity of human-mouse IgG1, IgG2, IgG3, and IgG4 chimeric monoclonal antibodies with antitumor specificity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900203-0

P-glycoprotein, multidrug resistance and tumor progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900203-0

Non-P-glycoprotein-mediated multidrug-resistant human KB cells selected in medium containing adriamycin, cepharanthine, and mezerein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900203-0

Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900203-0

Cellular Trafficking and Cytotoxicity of Anti-Cd19-Targeted Liposomal Doxorubicin in B Lymphoma Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900203-0

Treatment of Plasma Cell Myeloma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900203-0

Radioimmunotherapy of B-cell lymphoma with [131I]anti-B1 (anti-CD20) antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900203-0

10.1016/S0005-2736(00)00203-0

7 January 2021

Identifiers

DOI

1 reference

24 September 2017

1 reference